Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geraldine Perkins

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Clinics and Research in Hepatology and Gastroenterology|April 30, 2021
Chemotherapy use in end-of-life digestive cancer patients: a retrospective AGEO observational studyAlexandra Lapeyre-Prost, Geraldine Perkins, Marie Vallee, et al.
European Journal of Cancer (Oxford, England : 1990)|August 31, 2024
BRAF + EGFR +/- MEK inhibitors after immune checkpoint inhibitors in BRAF V600E mutated and deficient mismatch repair or microsatellite instability high metastatic colorectal cancerMargherita Ambrosini, David Tougeron, Dominik Modest, et al.
British Journal of Cancer|March 7, 2019
Can we classify ampullary tumours better? Clinical, pathological and molecular features. Results of an AGEO studyGeraldine Perkins, Magali Svrcek, Cecile Bouchet-Doumenq, et al.
Plos One|November 13, 2012
Multi-purpose utility of circulating plasma DNA testing in patients with advanced cancersGeraldine Perkins, Timothy A Yap, Lorna Pope, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 27, 2023
Features of colorectal adenomas among young patients with Lynch syndrome according to path_MMR: Results from the PRED-IdF registryHadrien Alric, Elise Coffin, Celine Lekhal, et al.
British Journal of Cancer|December 15, 2023
Primary resistance to immunotherapy in patients with a dMMR/MSI metastatic gastrointestinal cancer: who is at risk? An AGEO real-world studyClémence Flecchia, Edouard Auclin, Emily Alouani, et al.
Clinical Chemistry|June 3, 2016
A Study of Hypermethylated Circulating Tumor DNA as a Universal Colorectal Cancer BiomarkerSonia Garrigou, Geraldine Perkins, Fanny Garlan, et al.
Cancer Immunology Research|May 27, 2021
Complement C1s and C4d as Prognostic Biomarkers in Renal Cancer: Emergence of Noncanonical Functions of C1sMarie V Daugan, Margot Revel, Jules Russick, et al.
BMC Cancer|April 11, 2025
A Phase Ia/b study of MEK1/2 inhibitor binimetinib with MET inhibitor crizotinib in patients with RAS mutant advanced colorectal cancer (MErCuRIC)Francesca Aroldi, Elena Elez, Thierry André, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Clinics and Research in Hepatology and Gastroenterology|April 30, 2021
Chemotherapy use in end-of-life digestive cancer patients: a retrospective AGEO observational studyAlexandra Lapeyre-Prost, Geraldine Perkins, Marie Vallee, et al.
European Journal of Cancer (Oxford, England : 1990)|August 31, 2024
BRAF + EGFR +/- MEK inhibitors after immune checkpoint inhibitors in BRAF V600E mutated and deficient mismatch repair or microsatellite instability high metastatic colorectal cancerMargherita Ambrosini, David Tougeron, Dominik Modest, et al.
British Journal of Cancer|March 7, 2019
Can we classify ampullary tumours better? Clinical, pathological and molecular features. Results of an AGEO studyGeraldine Perkins, Magali Svrcek, Cecile Bouchet-Doumenq, et al.
Plos One|November 13, 2012
Multi-purpose utility of circulating plasma DNA testing in patients with advanced cancersGeraldine Perkins, Timothy A Yap, Lorna Pope, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 27, 2023
Features of colorectal adenomas among young patients with Lynch syndrome according to path_MMR: Results from the PRED-IdF registryHadrien Alric, Elise Coffin, Celine Lekhal, et al.
British Journal of Cancer|December 15, 2023
Primary resistance to immunotherapy in patients with a dMMR/MSI metastatic gastrointestinal cancer: who is at risk? An AGEO real-world studyClémence Flecchia, Edouard Auclin, Emily Alouani, et al.
Clinical Chemistry|June 3, 2016
A Study of Hypermethylated Circulating Tumor DNA as a Universal Colorectal Cancer BiomarkerSonia Garrigou, Geraldine Perkins, Fanny Garlan, et al.
Cancer Immunology Research|May 27, 2021
Complement C1s and C4d as Prognostic Biomarkers in Renal Cancer: Emergence of Noncanonical Functions of C1sMarie V Daugan, Margot Revel, Jules Russick, et al.
BMC Cancer|April 11, 2025
A Phase Ia/b study of MEK1/2 inhibitor binimetinib with MET inhibitor crizotinib in patients with RAS mutant advanced colorectal cancer (MErCuRIC)Francesca Aroldi, Elena Elez, Thierry André, et al.
Pageof 2